Latest News - Zimmer Biomet
Top Corporates Hub
Zimmer Biomet
ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT
13.10.2026 11:30
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced a multi-year extension of its Limited Exclusive Distribution and Supply Agreement following a successful partnership during the initial term of the agreement.
Zimmer Biomet Expands Its Distribution, Supply Deal With THINK Surgical To Continue Distribution Of THINK's Wireless TMINI Miniature Robotic System
13.10.2026 07:39
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced a multi-year extension of its
What Could Lift ISRG Stock?
06.10.2026 14:02
Intuitive Surgical (ISRG) stock has lost 8.2% over the past twelve months, while the S&P 500 returned 17.1%. If you own it, you have watched the market move on without you, and if you do not, the lower price may look tempting. Either way, you are counting on the business behind the da Vinci systems. So what would Intuitive have to sell more of for the stock to climb again.
Are Investors Undervaluing Baxter International (BAX) Right Now?
06.10.2026 12:40
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results
06.10.2026 11:30
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its third quarter earnings conference call will be webcast on Wednesday, November 4, 2026, at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET.
Zimmer Biomet (ZBH): Buy, Sell, or Hold Post Q2 Earnings?
26.09.2026 00:56
Zimmer Biomet currently trades at $91.50 per share and has shown little upside over the past six months, posting a middling return of 4.4%. The stock also fell short of the S&P 500’s 16.9% gain during that period.
Medical Robots Market Forecasts Growth from $20.6B (2026) to $41.7B by 2031, Profiling Intuitive Surgical, Stryker, Zimmer Biomet & Medtronic
24.09.2026 10:17
The global medical robots market is projected to grow from USD 20.6 billion in 2026 to USD 41.7 billion by 2031, at a 15.1% CAGR. Growth is driven by demand for minimally invasive surgery, healthcare automation, precision procedures, and advances in AI-powered surgical, rehabilitation, radiosurgery, hospital, and pharmacy robots. Robotic systems will hold the largest market share, while surgical robots will lead by type. Ambulatory surgery centers are set for the fastest end-user growth, and Asi
Minimally Invasive Robotic Surgical System Market Global Report 2026: Benchmark Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker and Zimmer Biomet Now
23.09.2026 10:50
Players: Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker, Zimmer Biomet. Profile covers competitors, segments, regional shares, trends and opportunities. Minimally Invasive Robotic Surgical System Market Minimally Invasive Robotic Surgical System Market Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Minimally Invasive Robotic Surgical System Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. Minimally Invasive Robotic Surgical System Market to Reach $18.15 Bil
How Far Could ISRG Stock Bounce From Here?
21.09.2026 15:05
Intuitive Surgical (ISRG) stock could climb 23.9% to the April high it last fell back from, and you would risk about 5% to find out. That looks like a surgical-robot leader on sale, but the price history disagrees. Over the last two years, none of its visits to this price range turned into a 20% gain before a 5% drop.
Treace Medical Looks Unlikely To Recover, A Founder-Led Broken Growth Story
20.09.2026 05:06
Treace Medical outlook: revenue declines, Lapiplasty losing share, margins compressing, and EBITDA delayed. Click for more on TMCI stock.
Get Paid To Wait For ISRG Stock To Go On Sale
14.09.2026 14:34
Intuitive Surgical (ISRG) trades near $370, about 38% below its 52-week high, after growth in its US robotic-surgery procedures slowed. Selling a put pays you now for agreeing to buy the shares much lower, and you keep the payment either way. The catch is it only works if you would want this business at that price.
Zimmer proposes to cut 580 jobs in Switzerland
14.09.2026 10:00
Reducing headcount at the Swiss site is part of an ongoing effort to simplify the company’s manufacturing footprint and supply chain.
Stryker: Operational Issues Have Created An Opportunity
14.09.2026 07:00
Stryker's share price declined significantly due to operational issues, valuation concerns, and weaker orthopedic procedure volume growth. Learn more about SYK stock here.
Global Surgical Robots Market to Reach $10.6 Billion in 2026, Driven by AI Integration and Minimally Invasive Surgery
07.09.2026 08:21
Report Features In-Depth Profiles of Abbott, Great Robotics, Intuitive Surgical, Johnson & Johnson, Medtronic, Panasonic, Renishaw, Siemens Healthineers, Smith+Nephew, Stryker, Zimmer Biomet, and FreehandDublin, Sept. 07, 2026 (GLOBE NEWSWIRE) -- The "Surgical Robots Market by Offering of Surgical Robot Developers, Deployment Model, Type of Surgical Procedure Supported, Application Area, End Users and Key Geographical Regions - Trends and Forecast Till 2035" has been added to ResearchAndMarkets.
Zimmer Biomet - Showing Signs Of Life
01.09.2026 09:41
Zimmer Biomet sees strong constant currency sales growth driven by transformation, R&D and M&A.
Enovis: Executing Better, But Still Remains Stuck In A Med-Tech No Man's Land
20.08.2026 10:39
Enovis is gaining share in joint reconstruction, leveraging new products and capitalizing on competitor disruptions. Learn more about ENOV stock here.
5 Revealing Analyst Questions From Zimmer Biomet’s Q2 Earnings Call
14.08.2026 09:49
Zimmer Biomet’s second quarter results were driven by strong execution in its hip franchise, robust technology sales, and progress in the U.S. sales force transformation. CEO Ivan Tornos highlighted that new product adoption, such as the Z1 hip stem and OrthoGrid navigation, contributed to above-average growth in the U.S. In addition, increased demand for the company’s technology and data solutions, including capital equipment sales, played a key role. Management attributed the quarter’s perform
Can Stryker's Q2 Recovery and Guidance Support a Stronger Second Half?
13.08.2026 17:49
Stryker enters the second half with Q2 momentum restored, but meeting guidance hinges on production, backlog conversion and managing cyber and supply risks.
Stryker Up 13.6% in 3 Months as Recovery Gains Strength, What's Next?
13.08.2026 17:49
Stryker's 13.6% three-month rally reflects stronger sales, margins and production, but execution risks and a premium peer valuation could test further gains.
Is SYK Worth Buying as Growth Improves but Execution Risks Persist?
13.08.2026 17:49
Stryker's stronger growth, margin gains and product pipeline support the case, but cyber costs, supply constraints and acquisition execution keep risks elevated.